Nanjing Well Pharmaceutical Co Ltd Tangible Net Worth Ratio
Nanjing Well Pharmaceutical Co Ltd tangible net worth ratio. Nanjing Well Pharmaceutical Co Ltd (603351) has a Tangible Net Worth Ratio of 94.2% as of March 2026. This metric is calculated by deducting intangible assets (CN¥106.93 Million) from net assets (CN¥1.84 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 603351 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Nanjing Well Pharmaceutical Co Ltd (2014–2025)
Tangible net worth ratio of Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025. This chart shows how Nanjing Well Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 94.2%, reflecting net assets of CN¥1.84 Billion with intangible assets of CN¥106.93 Million CNY. See Nanjing Well Pharmaceutical Co Ltd (603351) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Nanjing Well Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (2014–2025)
Nanjing Well Pharmaceutical Co Ltd tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Nanjing Well Pharmaceutical Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 603351 market cap.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.0% | CN¥1.80 Billion | CN¥107.68 Million | CN¥2.59 Billion | ▲ +0.6 pp |
| 2024 | 93.4% | CN¥1.71 Billion | CN¥111.91 Million | CN¥2.38 Billion | ▼ -0.4 pp |
| 2023 | 93.8% | CN¥1.59 Billion | CN¥98.37 Million | CN¥2.28 Billion | ▲ +0.1 pp |
| 2022 | 93.7% | CN¥1.48 Billion | CN¥93.53 Million | CN¥2.14 Billion | ▼ -0.7 pp |
| 2021 | 94.4% | CN¥1.39 Billion | CN¥77.48 Million | CN¥1.84 Billion | ▲ +0.4 pp |
| 2020 | 94.0% | CN¥1.30 Billion | CN¥78.49 Million | CN¥1.64 Billion | ▲ +0.4 pp |
| 2019 | 93.5% | CN¥1.24 Billion | CN¥80.14 Million | CN¥1.46 Billion | ▲ +0.5 pp |
| 2018 | 93.1% | CN¥614.61 Million | CN¥42.48 Million | CN¥808.20 Million | ▲ +1.0 pp |
| 2017 | 92.0% | CN¥532.80 Million | CN¥42.41 Million | CN¥725.52 Million | ▲ +1.8 pp |
| 2016 | 90.3% | CN¥443.99 Million | CN¥43.14 Million | CN¥600.23 Million | ▲ +5.2 pp |
| 2015 | 85.0% | CN¥294.49 Million | CN¥44.07 Million | CN¥487.50 Million | ▲ +3.6 pp |
| 2014 | 81.4% | CN¥240.35 Million | CN¥44.61 Million | CN¥419.30 Million | — |